Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|94|2|96-98

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.2, 2015-02, pp. : 96-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 257-263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk‐stratification and management

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 162-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

New and treatment‐relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 683-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased CD11/CD18 Expression and Altered Metabolic Activity on Polymorphonuclear Leukocytes from Patients with Polycythemia vera and Essential Thrombocythemia

By  

Acta Haematologica, Vol. 108, Iss. 1, 2002-07 ,pp. : 23-28

Karger

Access to resources Recommend Favorite

MicroRNA Expression and JAK2 Allele Burden in Bone Marrow Trephine Biopsies of Polycythemia Vera, Essential Thrombocythemia and Early Primary Myelofibrosis

By  

Acta Haematologica, Vol. 129, Iss. 4, 2013-01 ,pp. : 251-256

Karger

Access to resources Recommend Favorite